Off-the-shelf supplements are a guess. Personalised nutrition has been a luxury. Sync is what happens when granule technology, open science, and an AI research assistant collapse the gap between the two.
Three things, working together.
Personalisation is not a flavour. It’s a system: a delivery format, a biological read, and a research layer that ties them together.
Granule technology
Plant-based micro-granules, 0.2–2 mm, suspended in a guar-gum carrier. Built on a public-domain Swiss patent. One level spoonful a day — no capsules, no swallow.
Fourteen biomarkers
A short health profile maps fourteen markers of your biology to a formula of up to thirty-five actives. Your jar is refined each cycle as your numbers move.
AI research assistant
Every recommendation is grounded in cited literature. Ask Sync why a granule is in your jar — and it will show you the paper, the dose, and the trade-off.
Built by two people obsessed with the same problem.
Abhishek Gupta
Abhishek leads Sync. He spent six years in leadership at Honasa Consumer — the house of Mamaearth, The Derma Co. and Aqualogica — building D2C brands from category challengers to a publicly listed company. He's spent the last decade learning how a personal-care product actually gets into a customer's hands, at scale, in India.
Ojaswa Sharma
Ojaswa leads product, research, and design at Sync. He trained at IIM Calcutta, Reforge, and UC San Diego in Human-Centered Design, and has spent the last decade building consumer products at the intersection of behaviour, data, and craft. He has built solutions and teams at leading startups like CarDekho, Policybazaar, and most recently Honasa Consumer Limited — solving problems that to some seemed impossible while leading crucial charge in the successful IPOs of Policybazaar and Honasa. Ojaswa also advises and invests in technology and consumer D2C startups.
Be early.
We’re opening Sync to a small founding cohort in 2026. Leave an email — one update a month, never more.